IRIS
MARRELLI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.947
EU - Europa 23.281
AS - Asia 12.987
SA - Sud America 2.203
AF - Africa 769
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 21
Totale 68.256
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.570
GB - Regno Unito 5.245
RU - Federazione Russa 4.878
CN - Cina 4.534
SG - Singapore 4.008
IE - Irlanda 3.129
IT - Italia 2.406
BR - Brasile 1.837
UA - Ucraina 1.763
SE - Svezia 1.550
FR - Francia 1.453
VN - Vietnam 1.340
DE - Germania 1.280
HK - Hong Kong 1.086
FI - Finlandia 677
KR - Corea 597
IN - India 341
ZA - Sudafrica 322
ES - Italia 195
CA - Canada 184
BD - Bangladesh 145
AR - Argentina 144
IQ - Iraq 125
NG - Nigeria 120
TR - Turchia 118
NL - Olanda 115
MX - Messico 114
BE - Belgio 105
PL - Polonia 98
JP - Giappone 90
ID - Indonesia 78
CI - Costa d'Avorio 76
PK - Pakistan 58
AT - Austria 53
IR - Iran 53
SA - Arabia Saudita 52
EG - Egitto 49
LT - Lituania 44
RO - Romania 43
JO - Giordania 42
EC - Ecuador 41
KE - Kenya 41
VE - Venezuela 41
MA - Marocco 39
AU - Australia 38
UZ - Uzbekistan 36
CL - Cile 33
CZ - Repubblica Ceca 33
PH - Filippine 33
PT - Portogallo 31
PY - Paraguay 31
NP - Nepal 28
AE - Emirati Arabi Uniti 27
MU - Mauritius 27
TN - Tunisia 27
CO - Colombia 26
AZ - Azerbaigian 25
MY - Malesia 25
CH - Svizzera 23
KG - Kirghizistan 23
PE - Perù 21
DZ - Algeria 19
KZ - Kazakistan 19
UY - Uruguay 19
IL - Israele 18
ET - Etiopia 17
GR - Grecia 17
EU - Europa 16
AL - Albania 14
SI - Slovenia 13
BG - Bulgaria 12
LV - Lettonia 12
TH - Thailandia 12
PA - Panama 11
SN - Senegal 11
TW - Taiwan 11
EE - Estonia 10
MD - Moldavia 10
BO - Bolivia 9
CR - Costa Rica 9
DK - Danimarca 9
HN - Honduras 9
NZ - Nuova Zelanda 9
RS - Serbia 9
TT - Trinidad e Tobago 9
HU - Ungheria 8
JM - Giamaica 8
LU - Lussemburgo 8
DO - Repubblica Dominicana 7
NI - Nicaragua 7
NO - Norvegia 7
AO - Angola 6
BH - Bahrain 6
BY - Bielorussia 6
HR - Croazia 6
SY - Repubblica araba siriana 6
AM - Armenia 5
CY - Cipro 5
GE - Georgia 5
LB - Libano 5
Totale 68.165
Salva come PNG Salva come JPEG
Città #
Southend 4.666
Dallas 4.105
Fairfield 3.121
Dublin 3.098
Singapore 2.141
Ashburn 2.001
Chandler 1.612
Jacksonville 1.518
Moscow 1.371
Woodbridge 1.370
Santa Clara 1.296
Wilmington 1.175
Seattle 1.132
Houston 1.104
Beijing 1.052
Hong Kong 1.042
Cambridge 990
San Jose 848
Ann Arbor 780
Hefei 650
Seoul 578
Princeton 575
Nanjing 479
The Dalles 467
Ho Chi Minh City 400
Los Angeles 396
Siena 387
Munich 354
Council Bluffs 350
New York 349
Lauterbourg 342
Hanoi 328
Johannesburg 287
Helsinki 278
Boardman 232
San Mateo 227
Shanghai 188
São Paulo 187
Milan 180
San Diego 165
Buffalo 160
Florence 154
Shenyang 146
Nanchang 141
Columbus 131
Málaga 125
Orem 118
Abuja 111
London 105
Rome 103
Redondo Beach 101
Brussels 98
Tianjin 98
Frankfurt am Main 93
Dong Ket 89
Hebei 89
Changsha 81
Turku 81
Düsseldorf 78
Abidjan 76
Tokyo 75
Warsaw 75
San Francisco 72
Kunming 68
Jiaxing 66
Da Nang 64
Jinan 62
Chicago 59
Chennai 58
Bengaluru 57
Guangzhou 57
Manchester 57
Montreal 57
Rio de Janeiro 56
Phoenix 54
Toronto 53
Dearborn 50
Brooklyn 49
Menlo Park 48
Stockholm 47
Ningbo 46
Norwalk 46
Venezia 46
Boston 45
Denver 45
Zhengzhou 45
Atlanta 42
Baghdad 42
Belo Horizonte 42
Haiphong 42
Lappeenranta 40
Amman 37
Brasília 37
Washington 37
Bologna 36
Mumbai 35
Poplar 35
Vienna 35
Mexico City 34
Nuremberg 34
Totale 45.984
Salva come PNG Salva come JPEG
Nome #
Patologie del duodeno 608
612. Molecular background of high risk and low risk areas of gastric cancer in Italy 462
354. KRAS mutation in gastric cancer- molecular, and clinico-pathological characteristic 361
Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) 361
Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: A multicentre GIRCG study 353
65. Molecular surgery for gastric cancer-role of microsatellite instability in elderly patients 337
530. Minimally invasive surgery for the treatment of colo-rectal adenocarcinoma: Laparoscopic and robotic approach 330
613. Lymph node metastases in microsatellite unstable gastric cancer 328
338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer 328
C-Met targeting in advanced gastric cancer: An open challenge 327
A clinical case of duodenal gastrointestinal stromal tumor with a peculiarity in the surgical approach. 321
A case of pancreatic somatostatinoma [Considerazioni su un caso di somatostatinoma a localizzazione pancreatica] 318
353. PIK3CA mutation in gastric cancer and the role of different codon mutations in the new molecular division of that neoplasm 313
611. Gastric cancer patients with familial aggregation of gastric cancer and Lynch syndrome associated cancers with microsatellite instability 310
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 308
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 305
Accuracy of MDCT in the Preoperative Definition of Peritoneal Cancer Index (PCI) in Patients with Advanced Ovarian Cancer Who Underwent Peritonectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 300
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 297
610. Heterogeneity of new molecular gastric cancer classifications. Clinico-pathological characteristic 296
Clinical evaluation of the Mannheim Prognostic Index in post-operative peritonitis: a prospective cohort study 295
Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence 291
A case of small-cell gastric carcinoma with an adenocarcinoma component and hepatic metastases: treatment with systemic and intra-hepatic chemotherapy 290
Age Related Co-Morbidities in Colorectal Cancer Patients: Surgical Problems and Prognostic Impact 287
Familial aggregation of gastric cancer with microsatellite instability** 282
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 281
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 276
Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases 272
A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables 269
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 269
A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. 269
Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability 268
Robotic versus laparoscopic gastrectomy for gastric cancer: protocol for umbrella review of systematic reviews and meta-analyses 268
Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: Old problems and new perspectives 266
CA 19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions 266
High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability 265
Recurrence after surgery in esophago-gastric junction adenocarcinoma: Current management and future perspectives 263
Clinical impact of molecular classifications in gastric cancer 262
Accuracy of MDCT in preoperative definition of maximum tumour diameter in patients with gastric cancer 261
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. 260
Hyperthermic intrathoracic chemotherapy after extended pleurectomy and decortication for malignant pleura mesothelioma: An observational study on outcome and microcirculatory changes 260
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status 258
A rare case of primary small bowel adenocarcinoma with intussusception. 257
Re-evaluation of Mannheim prognostic index in perforative peritonitis: Prognostic role of advanced age. A prospective cohort study 257
Complications after surgery for gastric cancer in patients aged 80 years and over 257
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 256
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 255
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 255
Signet ring cell percentage in poorly cohesive gastric cancer patients: a potential novel predictor of survival 255
Antimicrobial prophylaxis reduces the rate of surgical site infection in upper gastrointestinal surgery: a systematic review 255
Is sleeve gastrectomy a therapeutic procedure for all obese patients? 252
E-cadherin and hereditary diffuse gastric cancer. 251
K-RAS mutation in gastric cancer and its link with microsatellite instability status 250
Computed Tomographic Evaluation of Mesentery : Diagnostic Value in Acute Mesenteric Ischemia. 249
The pattern of lymph node metastases in microsatellite unstable gastric cancer 249
Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer 249
CDH1 C-160A promoter polymorphism and gastric cancer risk 247
Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases 247
A comprehensive PDX gastric cancer collection captures cancer cell–intrinsic transcriptional MSI traits 247
Evidence of tumor microsatellite instability in gastric cancer with familial aggregation 246
Accuracy of MDCT in preoperative definition of maximum tumor diameter in patients with gastric cancer 244
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 242
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 242
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 241
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 240
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an italian family 240
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer 239
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer 238
The percentage of signet ring cells is inversely related to aggressive behavior and poor prognosis in mixed-type gastric cancer 237
Carcinomi squamosi e adenosquamosi del colon-retto: descrizione di tre casi clinici e revisione della letteratura 237
Accuracy of MDCT in preoperative definition of maximum tumor diameter in patients with gastric cancer 237
Presacral ganglioneuroma: a case report and review of literature 235
Clinical and oncological value of preoperative BMI in gastric cancer patients: A single center experience 235
Robotic single docking total colectomy for ulcerative colitis: First experience with a novel technique 230
Potential impact of molecular classification on tailored lymphadenectomy for gastric cancer 228
High incidence of familial gastric cancer in Tuscany, a region in Italy. 226
Treatment of the intraabdominal abscesses through percutaneous ultrasound-guided drainage in oncological patients: Clinical and microbiological data. 226
Approccio multimodale al trattamento delle metastasi epatiche. 225
Clinical Outcome of Primary and Postoperative Visceral Perforations 224
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 224
Il ruolo della chemioipertermia nel carcinoma del colon-retto 223
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data 223
Super-extended (D3) lymphadenectomy in advanced gastric cancer. 222
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 222
Factors influencing survival after hepatectomy for metastases from gastric cancer 221
Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study 221
Western Experience of Hepatolithiasis: Clinical Insights from a Case Series in a Tertiary Center 220
Elastofibroma dorsi: three cases of personal experience 220
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 220
Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial 219
Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy. 218
609. Pathology of signet-ring cell in gastric cancer and its prognostic value in surgical treatment 217
From digital world to real life: A robotic approach to the esophagogastric junction with a 3D printed model 215
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study 214
Gastric linitis plastica: which role for surgical resection? 213
An aggressive early gastric cancer: Kodama's PenA type 213
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 213
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 211
Cell kinetic patterns in early gastric cancer 210
Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. 210
Histological variety of gastric carcinoma and Helicobacter pylori cagA and vacA polymorphism 210
Totale 26.320
Salva come PNG Salva come JPEG
Categoria #
all - tutte 206.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 206.064
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.380 0 0 0 0 0 0 0 0 0 464 487 429
2021/20224.288 375 532 279 293 218 167 208 147 224 463 477 905
2022/20236.032 352 384 815 860 587 1.320 146 465 601 177 171 154
2023/20244.581 222 137 374 164 149 1.215 1.681 82 25 161 59 312
2024/20259.796 315 517 804 484 1.311 676 235 573 839 390 1.143 2.509
2025/202622.282 1.838 3.682 2.937 2.735 4.473 991 2.735 737 976 1.178 0 0
Totale 68.840